Biotechnology
The Biotechnology industry has a total of 614 stocks, with a combined market cap of $1.01 trillion and total revenue of $105.07 billion.
Market Cap
1.01T
Revenue
105.07B
Profits
-42.27B
PE Ratio
n/a
Profit Margin
-40.23%
Dividend Yield
0.04%
614 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 103.89B | -1.63% | 1,357,709 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.46B | 1.65% | 688,281 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 58.49B | 0.50% | 742,307 | 3.21B |
| 4 | ARGX | argenx SE | 51.75B | 0.43% | 268,608 | 3.68B |
| 5 | INSM | Insmed Incorporated | 40.46B | 2.17% | 2,191,555 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.41B | -3.73% | 339,925 | 4.97B |
| 7 | BNTX | BioNTech SE | 24.80B | -0.20% | 506,305 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.26B | -5.44% | 9,326,678 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.81B | 0.74% | 2,019,426 | 4.81B |
| 10 | GMAB | Genmab A/S | 17.64B | -0.62% | 2,026,109 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.25B | 0.24% | 9,417,372 | 23.23M |
| 12 | SMMT | Summit Therapeutics Inc. | 13.53B | -1.46% | 2,684,516 | - |
| 13 | ASND | Ascendis Pharma A/S | 12.08B | -0.77% | 316,414 | 576.33M |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 11.91B | -0.74% | 2,325,183 | 966.96M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 11.91B | -1.48% | 2,341,406 | 353.78M |
| 16 | RVMD | Revolution Medicines, Inc. | 11.79B | -0.60% | 2,723,844 | - |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.11B | 0.14% | 294,182 | 740.64M |
| 18 | EXEL | Exelixis, Inc. | 10.99B | 0.02% | 2,311,471 | 2.29B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.03B | 0.09% | 6,153,277 | 10.73M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 9.89B | -0.73% | 3,091,266 | 3.09B |
| 21 | MRNA | Moderna, Inc. | 9.59B | 0.86% | 10,383,002 | 2.23B |
| 22 | TECH | Bio-Techne Corporation | 8.95B | -1.32% | 1,755,603 | 1.22B |
| 23 | MTSR | Metsera, Inc. | 8.75B | 2.00% | 1,923,306 | - |
| 24 | HALO | Halozyme Therapeutics, Inc. | 8.02B | -0.22% | 11,676,140 | 1.24B |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 7.97B | -2.16% | 1,041,646 | 4.16B |
| 26 | CORT | Corcept Therapeutics Incorporated | 7.75B | 0.90% | 644,870 | 741.17M |
| 27 | ABVX | ABIVAX Société Anonyme | 7.74B | 1.32% | 925,770 | 7.07M |
| 28 | CYTK | Cytokinetics, Incorporated | 7.36B | -0.23% | 1,879,894 | 87.21M |
| 29 | CAI | Caris Life Sciences, Inc. | 7.23B | 4.06% | 2,742,649 | 649.06M |
| 30 | MRUS | Merus N.V. | 7.22B | 0.07% | 1,303,798 | 56.61M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 6.96B | -0.90% | 459,010 | 561.26M |
| 32 | NUVL | Nuvalent, Inc. | 6.79B | -2.63% | 289,220 | - |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.69B | 1.82% | 1,155,095 | 174.33M |
| 34 | LEGN | Legend Biotech Corporation | 5.87B | -1.76% | 1,058,519 | 796.84M |
| 35 | PTCT | PTC Therapeutics, Inc. | 5.76B | -1.14% | 1,149,135 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.74B | -1.02% | 249,318 | 373.16M |
| 37 | PCVX | Vaxcyte, Inc. | 5.45B | -0.14% | 981,896 | - |
| 38 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.42B | -0.93% | 1,307,902 | 572.98M |
| 39 | CRSP | CRISPR Therapeutics AG | 5.01B | -2.63% | 2,929,446 | 38.05M |
| 40 | ACLX | Arcellx, Inc. | 5.00B | -1.87% | 291,578 | 35.90M |
| 41 | PTGX | Protagonist Therapeutics, Inc. | 4.97B | -0.30% | 882,286 | 209.22M |
| 42 | TGTX | TG Therapeutics, Inc. | 4.71B | -3.07% | 1,762,284 | 531.90M |
| 43 | AKRO | Akero Therapeutics, Inc. | 4.45B | 0.24% | 1,116,618 | - |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.22B | -3.56% | 599,945 | 43.74M |
| 45 | PRAX | Praxis Precision Medicines, Inc. | 4.21B | -2.40% | 514,972 | 7.46M |
| 46 | VKTX | Viking Therapeutics, Inc. | 4.16B | -1.34% | 4,647,523 | - |
| 47 | NAMS | NewAmsterdam Pharma Company N.V. | 4.14B | -0.78% | 883,677 | 35.24M |
| 48 | IMVT | Immunovant, Inc. | 4.07B | -1.35% | 1,580,697 | - |
| 49 | BLTE | Belite Bio, Inc | 3.95B | 1.31% | 208,994 | - |
| 50 | ACAD | ACADIA Pharmaceuticals Inc. | 3.82B | 4.25% | 1,557,609 | 1.05B |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.80B | -8.02% | 4,059,788 | 1.54M |
| 52 | APGE | Apogee Therapeutics, Inc. | 3.58B | -0.45% | 522,585 | - |
| 53 | MIRM | Mirum Pharmaceuticals, Inc. | 3.50B | 0.62% | 690,287 | 471.79M |
| 54 | ADMA | ADMA Biologics, Inc. | 3.46B | 3.49% | 4,568,043 | 488.56M |
| 55 | TLX | Telix Pharmaceuticals Limited | 3.29B | -1.72% | 180,480 | 664.23M |
| 56 | CDTX | Cidara Therapeutics, Inc. | 3.28B | 5.83% | 954,488 | 302.00K |
| 57 | IRON | Disc Medicine, Inc. | 3.17B | -3.64% | 270,668 | - |
| 58 | CELC | Celcuity Inc. | 3.16B | 0.43% | 446,970 | - |
| 59 | CGON | CG Oncology, Inc. | 3.03B | -0.03% | 635,534 | 551.00K |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | -3.47% | 3,019,422 | 317.93M |
| 61 | CNTA | Centessa Pharmaceuticals plc | 2.97B | -3.15% | 1,935,330 | 15.00M |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 2.96B | -0.13% | 475,358 | 7.50M |
| 63 | RARE | Ultragenyx Pharmaceutical Inc. | 2.95B | -1.03% | 1,355,231 | 630.60M |
| 64 | MLYS | Mineralys Therapeutics, Inc. | 2.95B | 2.73% | 1,189,040 | - |
| 65 | AAPG | Ascentage Pharma Group International | 2.95B | -1.95% | 3,773 | 54.52M |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 2.90B | 0.23% | 565,822 | 366.10M |
| 67 | TVTX | Travere Therapeutics, Inc. | 2.89B | -2.88% | 2,594,766 | 435.83M |
| 68 | SRRK | Scholar Rock Holding Corporation | 2.78B | 0.52% | 1,715,469 | - |
| 69 | FOLD | Amicus Therapeutics, Inc. | 2.74B | -0.34% | 3,890,765 | 598.70M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 2.65B | 1.31% | 926,818 | 214.83M |
| 71 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.63B | 1.91% | 1,942,422 | 578.20M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.62B | 0.82% | 3,610,594 | - |
| 73 | VRDN | Viridian Therapeutics, Inc. | 2.62B | -0.22% | 1,117,964 | 70.79M |
| 74 | SLNO | Soleno Therapeutics, Inc. | 2.56B | 9.55% | 3,946,831 | 98.68M |
| 75 | APLS | Apellis Pharmaceuticals, Inc. | 2.44B | -2.28% | 5,096,646 | 1.02B |
| 76 | ZLAB | Zai Lab Limited | 2.44B | -5.40% | 1,005,197 | 441.63M |
| 77 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | - | 52,623,449 | 43.69M |
| 78 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | 0.89% | 369,787 | 44.79M |
| 79 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 2.07% | 1,604,769 | 55.78M |
| 80 | LQDA | Liquidia Corporation | 2.27B | 1.91% | 1,824,717 | 69.22M |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 2.26B | -4.95% | 2,944,463 | 252.75M |
| 82 | DNLI | Denali Therapeutics Inc. | 2.20B | 4.23% | 2,053,611 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.19B | -4.06% | 2,276,803 | 55.70M |
| 84 | COGT | Cogent Biosciences, Inc. | 2.11B | 0.68% | 3,193,679 | - |
| 85 | IBRX | ImmunityBio, Inc. | 2.10B | 0.47% | 10,641,797 | 82.56M |
| 86 | RCUS | Arcus Biosciences, Inc. | 2.08B | -1.28% | 1,555,614 | 240.00M |
| 87 | GLPG | Galapagos NV | 2.05B | 1.06% | 200,836 | 336.64M |
| 88 | VCEL | Vericel Corporation | 1.97B | 0.49% | 815,727 | 258.72M |
| 89 | AUPH | Aurinia Pharmaceuticals Inc. | 1.93B | 4.73% | 2,461,823 | 265.81M |
| 90 | GPCR | Structure Therapeutics Inc. | 1.89B | -1.88% | 786,046 | - |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.06% | 4,187,318 | 2.41B |
| 92 | MESO | Mesoblast Limited | 1.84B | -2.14% | 268,880 | 17.20M |
| 93 | EWTX | Edgewise Therapeutics, Inc. | 1.82B | 0.47% | 744,399 | - |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.81B | 1.58% | 860,167 | 825.94M |
| 95 | ZBIO | Zenas BioPharma, Inc. | 1.80B | 3.54% | 338,887 | 15.00M |
| 96 | SYRE | Spyre Therapeutics, Inc. | 1.75B | 0.58% | 568,802 | - |
| 97 | MNKD | MannKind Corporation | 1.73B | -1.23% | 3,176,257 | 313.79M |
| 98 | QURE | uniQure N.V. | 1.71B | 1.02% | 3,999,180 | 14.34M |
| 99 | IMCR | Immunocore Holdings plc | 1.69B | 6.01% | 334,002 | 379.59M |
| 100 | NUVB | Nuvation Bio Inc. | 1.62B | -5.78% | 6,825,647 | 26.75M |
| 101 | TERN | Terns Pharmaceuticals, Inc. | 1.62B | 1.21% | 3,463,287 | - |
| 102 | JANX | Janux Therapeutics, Inc. | 1.59B | -7.61% | 1,749,806 | 10.00M |
| 103 | PHVS | Pharvaris N.V. | 1.56B | -0.96% | 103,660 | - |
| 104 | INVA | Innoviva, Inc. | 1.56B | 1.36% | 1,106,695 | 388.52M |
| 105 | DNTH | Dianthus Therapeutics, Inc. | 1.56B | -0.22% | 493,397 | 3.08M |
| 106 | SION | Sionna Therapeutics, Inc. | 1.55B | 0.90% | 224,508 | - |
| 107 | VERA | Vera Therapeutics, Inc. | 1.55B | -4.08% | 1,301,000 | - |
| 108 | CLDX | Celldex Therapeutics, Inc. | 1.52B | -1.55% | 770,647 | 5.79M |
| 109 | IMNM | Immunome, Inc. | 1.40B | -1.68% | 1,664,412 | 9.68M |
| 110 | MAZE | Maze Therapeutics, Inc. | 1.38B | -3.48% | 333,577 | 2.50M |
| 111 | ARDX | Ardelyx, Inc. | 1.36B | -1.06% | 2,694,766 | 398.23M |
| 112 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.35B | -1.20% | 1,901,558 | -665.00K |
| 113 | ORKA | Oruka Therapeutics, Inc. | 1.34B | -1.87% | 516,893 | - |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.34B | - | 991,313 | - |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.31B | 2.38% | 2,162,813 | 111.30M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.31B | 1.74% | 1,062,393 | 205.63M |
| 117 | WVE | Wave Life Sciences Ltd. | 1.25B | -0.25% | 3,284,473 | 93.95M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.25B | -1.68% | 946,061 | 83.69M |
| 119 | UPB | Upstream Bio, Inc. | 1.24B | -2.96% | 271,636 | 2.80M |
| 120 | XERS | Xeris Biopharma Holdings, Inc. | 1.23B | -3.63% | 5,536,382 | 266.14M |
| 121 | ZYME | Zymeworks Inc. | 1.23B | -8.04% | 1,481,623 | 134.48M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.22B | 1.18% | 554,030 | - |
| 123 | NVAX | Novavax, Inc. | 1.21B | -1.98% | 5,056,585 | 1.06B |
| 124 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | -1.59% | 800,928 | - |
| 125 | CVAC | CureVac N.V. | 1.17B | -0.76% | 665,603 | 599.54M |
| 126 | INBX | Inhibrx Biosciences, Inc. | 1.17B | -0.37% | 196,360 | 1.40M |
| 127 | ABCL | AbCellera Biologics Inc. | 1.17B | -13.69% | 13,529,797 | 35.33M |
| 128 | PGEN | Precigen, Inc. | 1.16B | -0.51% | 3,364,808 | 4.34M |
| 129 | MNMD | Mind Medicine (MindMed) Inc. | 1.15B | 3.17% | 2,207,530 | - |
| 130 | MBX | MBX Biosciences, Inc. | 1.15B | 3.35% | 907,606 | - |
| 131 | PHAR | Pharming Group N.V. | 1.11B | 4.97% | 23,454 | 362.27M |
| 132 | NTLA | Intellia Therapeutics, Inc. | 1.10B | -22.73% | 25,410,796 | 57.53M |
| 133 | MDXG | MiMedx Group, Inc. | 1.10B | 1.50% | 880,995 | 393.44M |
| 134 | IMTX | Immatics N.V. | 1.10B | -2.00% | 340,294 | 152.82M |
| 135 | ANAB | AnaptysBio, Inc. | 1.10B | 3.80% | 377,542 | 169.47M |
| 136 | SANA | Sana Biotechnology, Inc. | 1.09B | 0.99% | 5,469,111 | - |
| 137 | URGN | UroGen Pharma Ltd. | 1.09B | -1.27% | 2,073,026 | 96.52M |
| 138 | NKTR | Nektar Therapeutics | 1.06B | 1.54% | 858,835 | 62.60M |
| 139 | TNGX | Tango Therapeutics, Inc. | 1.06B | -1.75% | 2,339,884 | 66.50M |
| 140 | TSHA | Taysha Gene Therapies, Inc. | 1.05B | -2.30% | 4,034,832 | 6.31M |
| 141 | RLAY | Relay Therapeutics, Inc. | 1.05B | -7.35% | 4,987,122 | 8.36M |
| 142 | ELVN | Enliven Therapeutics, Inc. | 1.04B | -3.66% | 577,794 | - |
| 143 | FTRE | Fortrea Holdings Inc. | 1.04B | 2.09% | 1,814,984 | 2.76B |
| 144 | OCS | Oculis Holding AG | 1.01B | -0.93% | 39,113 | 960.67K |
| 145 | DAWN | Day One Biopharmaceuticals, Inc. | 999.03M | 8.23% | 5,789,045 | 133.67M |
| 146 | RZLT | Rezolute, Inc. | 997.75M | 12.08% | 2,048,039 | - |
| 147 | XNCR | Xencor, Inc. | 992.61M | -0.71% | 897,740 | 150.13M |
| 148 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 962.24M | -0.82% | 118,342 | - |
| 149 | NBTX | Nanobiotix S.A. | 950.24M | 1.02% | 78,447 | 11.93M |
| 150 | SVRA | Savara Inc. | 944.67M | -0.75% | 869,046 | - |
| 151 | ATAI | Atai Beckley N.V. | 934.52M | 0.46% | 3,928,280 | 2.31M |
| 152 | KOD | Kodiak Sciences Inc. | 929.17M | 4.32% | 622,441 | - |
| 153 | EYPT | EyePoint Pharmaceuticals, Inc. | 928.04M | 1.17% | 1,201,924 | 42.34M |
| 154 | PHAT | Phathom Pharmaceuticals, Inc. | 922.84M | 1.61% | 984,660 | 147.19M |
| 155 | IOVA | Iovance Biotherapeutics, Inc. | 913.03M | -0.43% | 29,618,392 | 250.43M |
| 156 | SPRY | ARS Pharmaceuticals, Inc. | 874.61M | 7.93% | 2,642,590 | 112.34M |
| 157 | BHVN | Biohaven Ltd. | 873.83M | -3.17% | 6,359,771 | - |
| 158 | ABUS | Arbutus Biopharma Corporation | 862.64M | 1.35% | 823,589 | 15.42M |
| 159 | PVLA | Palvella Therapeutics, Inc. | 860.77M | -1.02% | 103,903 | - |
| 160 | KURA | Kura Oncology, Inc. | 857.99M | -2.95% | 1,568,331 | 104.03M |
| 161 | PROK | ProKidney Corp. | 853.32M | 2.85% | 2,056,688 | 527.00K |
| 162 | CRMD | CorMedix Inc. | 843.04M | -0.19% | 1,810,388 | 121.48M |
| 163 | GHRS | GH Research PLC | 837.40M | 0.67% | 298,867 | - |
| 164 | SEPN | Septerna, Inc. | 825.27M | -1.54% | 182,158 | 726.00K |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 801.60M | -5.38% | 730,389 | 181.54M |
| 166 | BCAX | Bicara Therapeutics Inc. | 799.53M | 0.48% | 600,262 | - |
| 167 | TYRA | Tyra Biosciences, Inc. | 764.29M | 0.28% | 185,916 | - |
| 168 | MLTX | MoonLake Immunotherapeutics | 758.70M | 3.30% | 2,145,248 | - |
| 169 | CMPX | Compass Therapeutics, Inc. | 752.36M | 5.75% | 2,455,183 | 850.00K |
| 170 | TBPH | Theravance Biopharma, Inc. | 742.83M | -0.81% | 263,466 | 77.21M |
| 171 | MRVI | Maravai LifeSciences Holdings, Inc. | 733.88M | -0.69% | 1,363,677 | 192.44M |
| 172 | AVBP | ArriVent BioPharma, Inc. | 732.07M | -1.88% | 282,243 | - |
| 173 | VALN | Valneva SE | 727.41M | -2.02% | 113,604 | 230.57M |
| 174 | LENZ | LENZ Therapeutics, Inc. | 718.73M | 0.04% | 1,703,855 | 17.50M |
| 175 | VIR | Vir Biotechnology, Inc. | 713.71M | 0.20% | 1,693,156 | 16.86M |
| 176 | ATXS | Astria Therapeutics, Inc. | 706.00M | 0.64% | 588,040 | - |
| 177 | GERN | Geron Corporation | 683.04M | -0.93% | 12,140,001 | 183.40M |
| 178 | ARVN | Arvinas, Inc. | 682.70M | 6.30% | 2,600,225 | 312.30M |
| 179 | MGTX | MeiraGTx Holdings plc | 681.39M | 0.71% | 346,118 | 37.92M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 681.24M | -3.28% | 267,133 | - |
| 181 | PRME | Prime Medicine, Inc. | 674.52M | -8.85% | 5,945,245 | 5.98M |
| 182 | GYRE | Gyre Therapeutics, Inc. | 655.32M | -1.77% | 47,439 | 107.27M |
| 183 | REPL | Replimune Group, Inc. | 651.86M | -2.24% | 2,252,156 | - |
| 184 | ERAS | Erasca, Inc. | 643.93M | 1.34% | 2,471,520 | - |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 638.75M | -2.57% | 583,426 | 282.08M |
| 186 | YDES | YD Bio Limited | 632.18M | -7.12% | 94,608 | 510.36K |
| 187 | AVXL | Anavex Life Sciences Corp. | 626.17M | -1.49% | 1,599,246 | - |
| 188 | VTYX | Ventyx Biosciences, Inc. | 625.38M | -5.29% | 2,638,992 | - |
| 189 | CTMX | CytomX Therapeutics, Inc. | 613.36M | -13.60% | 7,773,376 | 113.63M |
| 190 | LXEO | Lexeo Therapeutics, Inc. | 597.77M | -2.73% | 2,851,679 | - |
| 191 | MNPR | Monopar Therapeutics Inc. | 583.20M | 0.24% | 209,926 | - |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 578.43M | -3.85% | 1,207,232 | 33.00K |
| 193 | OLMA | Olema Pharmaceuticals, Inc. | 573.10M | 1.95% | 569,949 | - |
| 194 | IVA | Inventiva S.A. | 572.01M | -4.07% | 106,838 | 19.93M |
| 195 | PRTA | Prothena Corporation plc | 568.44M | 4.76% | 927,099 | 11.79M |
| 196 | CRVS | Corvus Pharmaceuticals, Inc. | 567.58M | -2.81% | 946,234 | - |
| 197 | RGNX | REGENXBIO Inc. | 567.48M | 0.36% | 623,097 | 161.32M |
| 198 | EVMN | Evommune, Inc. | 553.73M | -9.00% | 347,055 | 3.00M |
| 199 | NAGE | Niagen Bioscience, Inc. | 547.81M | 3.64% | 1,264,335 | 124.71M |
| 200 | GOSS | Gossamer Bio, Inc. | 546.24M | 2.16% | 2,091,470 | 44.05M |
| 201 | KALV | KalVista Pharmaceuticals, Inc. | 544.64M | -1.01% | 802,722 | 1.43M |
| 202 | VSTM | Verastem, Inc. | 538.88M | 1.77% | 1,424,095 | 13.38M |
| 203 | DNA | Ginkgo Bioworks Holdings, Inc. | 508.68M | -20.80% | 2,962,737 | 180.61M |
| 204 | ABSI | Absci Corporation | 498.66M | -7.10% | 4,408,872 | 4.14M |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 495.98M | -3.08% | 1,146,498 | 84.39M |
| 206 | KROS | Keros Therapeutics, Inc. | 493.55M | 0.19% | 1,327,720 | 246.72M |
| 207 | ALMS | Alumis Inc. | 491.18M | - | 1,393,788 | 20.06M |
| 208 | ASMB | Assembly Biosciences, Inc. | 485.47M | -0.03% | 126,431 | 33.25M |
| 209 | DBVT | DBV Technologies S.A. | 485.19M | -0.43% | 123,254 | 5.50M |
| 210 | RAPT | RAPT Therapeutics, Inc. | 477.28M | -0.62% | 300,658 | - |
| 211 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 212 | NBP | NovaBridge Biosciences | 461.06M | -4.53% | 797,666 | - |
| 213 | ADCT | ADC Therapeutics SA | 454.50M | -2.88% | 946,151 | 77.25M |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 454.25M | -12.59% | 4,946,735 | 70.86M |
| 215 | OMER | Omeros Corporation | 448.49M | 0.15% | 1,254,619 | - |
| 216 | BCYC | Bicycle Therapeutics plc | 446.73M | -1.08% | 580,537 | 28.34M |
| 217 | IMRX | Immuneering Corporation | 435.71M | 4.08% | 2,031,893 | - |
| 218 | DSGN | Design Therapeutics, Inc. | 430.65M | 10.04% | 1,260,360 | - |
| 219 | ALT | Altimmune, Inc. | 428.48M | 4.31% | 4,257,900 | 20.00K |
| 220 | CGEM | Cullinan Therapeutics, Inc. | 424.76M | -2.18% | 710,596 | - |
| 221 | OCGN | Ocugen, Inc. | 424.73M | -1.45% | 6,115,625 | 5.37M |
| 222 | NMRA | Neumora Therapeutics, Inc. | 414.58M | -0.78% | 1,214,668 | - |
| 223 | FULC | Fulcrum Therapeutics, Inc. | 412.92M | -0.26% | 526,901 | 80.00M |
| 224 | DRUG | Bright Minds Biosciences Inc. | 402.56M | 4.78% | 82,648 | - |
| 225 | LCTX | Lineage Cell Therapeutics, Inc. | 401.91M | 1.73% | 1,908,670 | 10.82M |
| 226 | XOMA | XOMA Royalty Corporation | 401.19M | -2.58% | 26,083 | 44.95M |
| 227 | PRTC | PureTech Health plc | 394.58M | 1.51% | 5,871 | 6.39M |
| 228 | NGNE | Neurogene Inc. | 381.77M | 0.34% | 320,774 | 925.00K |
| 229 | TECX | Tectonic Therapeutic, Inc. | 361.60M | 1.74% | 639,683 | - |
| 230 | AUTL | Autolus Therapeutics plc | 353.97M | -2.21% | 2,934,453 | 29.93M |
| 231 | LBRX | LB Pharmaceuticals Inc | 344.50M | -1.03% | 147,097 | - |
| 232 | RCKT | Rocket Pharmaceuticals, Inc. | 343.06M | -1.86% | 2,118,351 | - |
| 233 | IVVD | Invivyd, Inc. | 339.84M | 2.92% | 2,868,649 | 50.04M |
| 234 | LYEL | Lyell Immunopharma, Inc. | 336.39M | -2.07% | 21,459 | 60.00K |
| 235 | BNTC | Benitec Biopharma Inc. | 335.74M | 6.58% | 391,487 | - |
| 236 | GALT | Galectin Therapeutics Inc. | 335.29M | -6.81% | 500,799 | - |
| 237 | AURA | Aura Biosciences, Inc. | 332.34M | -1.11% | 240,530 | - |
| 238 | DRTS | Alpha Tau Medical Ltd. | 328.27M | 1.47% | 31,644 | - |
| 239 | ACIU | AC Immune SA | 326.51M | -4.35% | 100,651 | 5.48M |
| 240 | CTNM | Contineum Therapeutics, Inc. | 318.82M | -0.77% | 136,189 | - |
| 241 | KRRO | Korro Bio, Inc. | 317.79M | 3.90% | 115,653 | 6.28M |
| 242 | PEPG | PepGen Inc. | 317.57M | 9.74% | 551,575 | - |
| 243 | ANNX | Annexon, Inc. | 316.47M | -4.64% | 1,637,287 | - |
| 244 | SLDB | Solid Biosciences Inc. | 316.32M | -3.68% | 965,549 | - |
| 245 | ANRO | Alto Neuroscience, Inc. | 312.74M | 3.77% | 556,749 | - |
| 246 | SLN | Silence Therapeutics plc | 310.80M | 2.02% | 145,207 | 25.83M |
| 247 | ENGN | enGene Holdings Inc. | 310.22M | 0.66% | 212,789 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 306.38M | 1.76% | 213,058 | 64.81M |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 306.00M | -4.82% | 380,730 | - |
| 250 | PBYI | Puma Biotechnology, Inc. | 301.84M | 22.24% | 2,366,075 | 212.00M |
| 251 | JBIO | Jade Biosciences, Inc. | 299.84M | 2.68% | 100,397 | - |
| 252 | LRMR | Larimar Therapeutics, Inc. | 296.14M | -0.29% | 1,452,603 | - |
| 253 | ETHZ | ETHZilla Corporation | 287.36M | 12.34% | 805,836 | - |
| 254 | MREO | Mereo BioPharma Group plc | 286.37M | 2.27% | 3,168,017 | 500.00K |
| 255 | KYTX | Kyverna Therapeutics, Inc. | 284.56M | -7.19% | 868,541 | - |
| 256 | ALDX | Aldeyra Therapeutics, Inc. | 282.16M | -2.49% | 624,460 | - |
| 257 | TENX | Tenax Therapeutics, Inc. | 281.13M | 1.59% | 36,737 | - |
| 258 | CADL | Candel Therapeutics, Inc. | 276.67M | 2.02% | 585,624 | - |
| 259 | EPRX | Eupraxia Pharmaceuticals Inc. | 276.19M | -2.33% | 54,492 | - |
| 260 | CAPR | Capricor Therapeutics, Inc. | 271.10M | -5.57% | 1,371,684 | 13.39M |
| 261 | ALLO | Allogene Therapeutics, Inc. | 265.18M | 12.38% | 3,138,013 | 22.00K |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 260.03M | -0.23% | 604,346 | 212.07M |
| 263 | AVIR | Atea Pharmaceuticals, Inc. | 259.50M | 0.62% | 346,298 | - |
| 264 | CBIO | Crescent Biopharma, Inc. | 256.69M | 0.23% | 144,463 | - |
| 265 | XFOR | X4 Pharmaceuticals, Inc. | 253.43M | 5.85% | 638,486 | 33.98M |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 251.36M | 2.20% | 1,144,252 | 15.74M |
| 267 | HUMA | Humacyte, Inc. | 249.07M | 1.53% | 5,847,483 | 818.00K |
| 268 | TRDA | Entrada Therapeutics, Inc. | 247.80M | -0.58% | 351,668 | 61.52M |
| 269 | FHTX | Foghorn Therapeutics Inc. | 246.56M | 9.00% | 165,658 | 24.52M |
| 270 | SGMT | Sagimet Biosciences Inc. | 244.56M | -2.21% | 489,315 | - |
| 271 | PYXS | Pyxis Oncology, Inc. | 243.45M | -3.22% | 561,984 | 2.82M |
| 272 | IMMP | Immutep Limited | 243.10M | 2.42% | 148,234 | 3.31M |
| 273 | CLLS | Cellectis S.A. | 239.52M | 1.92% | 80,630 | 82.55M |
| 274 | ZURA | Zura Bio Limited | 238.62M | 5.46% | 336,588 | - |
| 275 | ARCT | Arcturus Therapeutics Holdings Inc. | 236.79M | 5.19% | 1,177,085 | 122.12M |
| 276 | VYGR | Voyager Therapeutics, Inc. | 234.63M | 0.24% | 469,081 | 42.58M |
| 277 | ACHV | Achieve Life Sciences, Inc. | 234.57M | -3.16% | 928,132 | - |
| 278 | PRQR | ProQR Therapeutics N.V. | 233.86M | 0.45% | 526,627 | 18.86M |
| 279 | CABA | Cabaletta Bio, Inc. | 233.24M | 2.82% | 4,297,111 | - |
| 280 | MDWD | MediWound Ltd. | 225.14M | -2.61% | 37,315 | 19.86M |
| 281 | PALI | Palisade Bio, Inc. | 223.44M | 1.20% | 4,021,396 | - |
| 282 | EDIT | Editas Medicine, Inc. | 222.10M | -8.18% | 3,156,422 | 38.90M |
| 283 | FENC | Fennec Pharmaceuticals Inc. | 222.10M | -0.25% | 52,281 | 33.30M |
| 284 | BDTX | Black Diamond Therapeutics, Inc. | 221.48M | -2.26% | 1,128,104 | 70.00M |
| 285 | AARD | Aardvark Therapeutics, Inc. | 220.01M | 2.74% | 140,379 | - |
| 286 | CCCC | C4 Therapeutics, Inc. | 217.77M | -1.68% | 1,190,954 | 30.11M |
| 287 | FBRX | Forte Biosciences, Inc. | 215.42M | 5.59% | 65,878 | - |
| 288 | ABEO | Abeona Therapeutics Inc. | 215.37M | 0.24% | 2,607,298 | 400.00K |
| 289 | ARMP | Armata Pharmaceuticals, Inc. | 209.41M | 0.70% | 125,771 | 6.87M |
| 290 | TNYA | Tenaya Therapeutics, Inc. | 208.61M | -5.19% | 5,195,616 | - |
| 291 | TLSA | Tiziana Life Sciences Ltd | 207.94M | -2.78% | 336,002 | - |
| 292 | VTVT | vTv Therapeutics Inc. | 205.79M | 2.16% | 17,606 | 17.00K |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 205.57M | - | 326,455 | 2.94M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 204.65M | 4.24% | 101,822 | 1.09M |
| 295 | GNLX | Genelux Corporation | 202.38M | 2.26% | 421,863 | 8.00K |
| 296 | HRTX | Heron Therapeutics, Inc. | 201.70M | - | 2,315,626 | 155.10M |
| 297 | CAMP | Camp4 Therapeutics Corporation | 199.08M | -4.49% | 311,761 | 3.80M |
| 298 | SLS | SELLAS Life Sciences Group, Inc. | 198.87M | -1.85% | 3,509,207 | - |
| 299 | OABI | OmniAb, Inc. | 198.66M | - | 882,686 | 21.09M |
| 300 | AVTX | Avalo Therapeutics, Inc. | 197.94M | -2.46% | 620,895 | 192.00K |
| 301 | GNFT | Genfit S.A. | 197.43M | -1.77% | 13,565 | 52.99M |
| 302 | CRBU | Caribou Biosciences, Inc. | 194.63M | -2.34% | 2,962,004 | 9.12M |
| 303 | RLMD | Relmada Therapeutics, Inc. | 194.33M | 1.53% | 1,051,947 | - |
| 304 | NTHI | NeOnc Technologies Holdings, Inc. | 193.89M | 2.74% | 120,998 | 59.99K |
| 305 | NAUT | Nautilus Biotechnology, Inc. | 190.72M | - | 206,767 | - |
| 306 | PLX | Protalix BioTherapeutics, Inc. | 174.61M | -1.35% | 601,028 | 61.95M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 167.42M | -0.58% | 1,538,627 | - |
| 308 | TARA | Protara Therapeutics, Inc. | 165.52M | - | 312,765 | - |
| 309 | CYBN | Cybin Inc. | 165.20M | -1.48% | 488,467 | - |
| 310 | IPHA | Innate Pharma S.A. | 162.65M | -1.38% | 6,073 | 14.84M |
| 311 | CHRS | Coherus Oncology, Inc. | 161.97M | -10.07% | 2,921,296 | 277.73M |
| 312 | NVCT | Nuvectis Pharma, Inc. | 157.28M | 8.29% | 148,368 | - |
| 313 | MOLN | Molecular Partners AG | 152.84M | 1.28% | 3,567 | 856.30K |
| 314 | CDXS | Codexis, Inc. | 152.65M | -16.95% | 4,982,308 | 52.93M |
| 315 | CGEN | Compugen Ltd. | 151.53M | -1.22% | 325,637 | 22.14M |
| 316 | TNXP | Tonix Pharmaceuticals Holding Corp. | 149.02M | -2.35% | 831,895 | 9.83M |
| 317 | CRDF | Cardiff Oncology, Inc. | 147.52M | -2.67% | 1,401,066 | 501.00K |
| 318 | CGTX | Cognition Therapeutics, Inc. | 146.45M | - | 1,029,786 | - |
| 319 | GUTS | Fractyl Health, Inc. | 145.41M | 0.92% | 1,457,141 | 17.00K |
| 320 | RANI | Rani Therapeutics Holdings, Inc. | 145.17M | -11.01% | 6,465,647 | 1.20M |
| 321 | ELTX | Elicio Therapeutics, Inc. | 144.79M | -2.21% | 146,155 | - |
| 322 | ENTX | Entera Bio Ltd. | 143.38M | 0.96% | 129,070 | 166.00K |
| 323 | SAVA | Cassava Sciences, Inc. | 142.99M | - | 817,218 | - |
| 324 | SGMO | Sangamo Therapeutics, Inc. | 142.35M | 2.45% | 6,071,760 | 32.88M |
| 325 | ACTU | Actuate Therapeutics, Inc. | 140.74M | -1.77% | 35,344 | - |
| 326 | ALEC | Alector, Inc. | 139.71M | -1.54% | 1,976,865 | 69.05M |
| 327 | NKTX | Nkarta, Inc. | 139.21M | -0.51% | 1,028,375 | - |
| 328 | SPRO | Spero Therapeutics, Inc. | 138.44M | 2.93% | 514,706 | 48.58M |
| 329 | ANIX | Anixa Biosciences, Inc. | 137.92M | 3.20% | 112,903 | - |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 128.92M | 0.77% | 486,563 | - |
| 331 | VOR | Vor Biopharma Inc. | 128.17M | -1.42% | 331,725 | - |
| 332 | AGEN | Agenus Inc. | 126.82M | 3.65% | 437,235 | 101.71M |
| 333 | HURA | TuHURA Biosciences, Inc. | 126.12M | 2.86% | 157,300 | - |
| 334 | IRD | Opus Genetics, Inc. | 126.09M | -1.48% | 663,616 | 15.42M |
| 335 | STTK | Shattuck Labs, Inc. | 125.04M | 1.02% | 101,064 | 1.00M |
| 336 | CLYM | Climb Bio, Inc. | 124.01M | -6.15% | 511,518 | - |
| 337 | FATE | Fate Therapeutics, Inc. | 123.40M | 2.88% | 1,687,991 | 8.47M |
| 338 | ELDN | Eledon Pharmaceuticals, Inc. | 123.36M | -49.76% | 29,779,545 | - |
| 339 | MCRB | Seres Therapeutics, Inc. | 122.74M | 1.15% | 32,913 | 351.00K |
| 340 | VTGN | Vistagen Therapeutics, Inc. | 122.42M | -0.75% | 595,525 | 646.00K |
| 341 | APLT | Applied Therapeutics, Inc. | 122.41M | 13.74% | 2,773,908 | 121.00K |
| 342 | ACOG | Alpha Cognition Inc. | 119.56M | 0.35% | 272,110 | 4.59M |
| 343 | GLSI | Greenwich LifeSciences, Inc. | 118.04M | 5.35% | 104,218 | - |
| 344 | EXOZ | eXoZymes, Inc. | 117.42M | 3.70% | 791 | -700.00 |
| 345 | SEER | Seer, Inc. | 116.60M | -3.24% | 252,757 | 16.38M |
| 346 | ABOS | Acumen Pharmaceuticals, Inc. | 113.88M | -1.05% | 282,544 | - |
| 347 | INO | Inovio Pharmaceuticals, Inc. | 112.66M | -5.78% | 1,761,873 | 182.34K |
| 348 | TTRX | Turn Therapeutics Inc. | 112.65M | -5.41% | 40,387 | - |
| 349 | IKT | Inhibikase Therapeutics, Inc. | 111.77M | 0.67% | 76,368 | 1.00 |
| 350 | ESLA | Estrella Immunopharma, Inc. | 108.60M | 6.16% | 469,801 | - |
| 351 | ATOS | Atossa Therapeutics, Inc. | 105.99M | 0.74% | 881,289 | - |
| 352 | PTHS | Pelthos Therapeutics Inc. | 105.54M | -8.07% | 49,928 | - |
| 353 | SRZN | Surrozen, Inc. | 104.56M | -2.40% | 90,304 | 3.60M |
| 354 | ACET | Adicet Bio, Inc. | 103.42M | -5.50% | 2,431,590 | - |
| 355 | ONCY | Oncolytics Biotech Inc. | 103.27M | 0.99% | 503,249 | - |
| 356 | IMMX | Immix Biopharma, Inc. | 102.90M | 3.96% | 457,215 | - |
| 357 | TIL | Instil Bio, Inc. | 101.87M | 0.47% | 67,018 | - |
| 358 | CNTX | Context Therapeutics Inc. | 100.47M | 4.67% | 198,791 | - |
| 359 | ANEB | Anebulo Pharmaceuticals, Inc. | 99.43M | -3.20% | 63,856 | - |
| 360 | PLRX | Pliant Therapeutics, Inc. | 98.22M | 4.58% | 1,011,125 | - |
| 361 | TVGN | Tevogen Bio Holdings Inc. | 98.18M | 6.37% | 944,942 | - |
| 362 | WHWK | Whitehawk Therapeutics, Inc. | 97.56M | -1.43% | 266,895 | 14.38M |
| 363 | BMEA | Biomea Fusion, Inc. | 96.86M | 5.38% | 1,171,186 | - |
| 364 | COYA | Coya Therapeutics, Inc. | 96.34M | - | 153,955 | 423.45K |
| 365 | OVID | Ovid Therapeutics Inc. | 93.86M | -0.75% | 1,527,256 | 6.65M |
| 366 | CSBR | Champions Oncology, Inc. | 92.93M | -2.03% | 12,870 | 56.88M |
| 367 | IMA | ImageneBio, Inc. | 92.70M | -2.26% | 17,563 | 4.30M |
| 368 | ZNTL | Zentalis Pharmaceuticals, Inc. | 92.33M | -1.54% | 1,076,331 | 26.87M |
| 369 | OKYO | OKYO Pharma Limited | 92.15M | -6.84% | 125,372 | - |
| 370 | VXRT | Vaxart, Inc. | 91.38M | 5.35% | - | 80.72M |
| 371 | ADVM | Adverum Biotechnologies, Inc. | 90.65M | 0.93% | 304,496 | 1.00M |
| 372 | PRLD | Prelude Therapeutics Incorporated | 90.60M | -11.85% | 1,091,496 | 7.00M |
| 373 | VANI | Vivani Medical, Inc. | 90.05M | 3.40% | 336,413 | - |
| 374 | KLRS | Kalaris Therapeutics, Inc. | 88.84M | 0.42% | 294,454 | - |
| 375 | KPTI | Karyopharm Therapeutics Inc. | 87.98M | -1.15% | 91,770 | 142.53M |
| 376 | ORMP | Oramed Pharmaceuticals Inc. | 87.27M | -0.45% | 86,258 | 2.00M |
| 377 | MGNX | MacroGenics, Inc. | 86.59M | 0.74% | 526,997 | 165.50M |
| 378 | CNTB | Connect Biopharma Holdings Limited | 86.37M | -6.63% | 148,406 | 1.97M |
| 379 | SLGL | Sol-Gel Technologies Ltd. | 85.34M | -4.30% | 4,475 | 23.93M |
| 380 | ARTV | Artiva Biotherapeutics, Inc. | 84.51M | 0.58% | 208,555 | 251.00K |
| 381 | QNCX | Quince Therapeutics, Inc. | 83.79M | -1.89% | 178,266 | - |
| 382 | IFRX | InflaRx N.V. | 83.33M | 2.50% | 25,890,685 | 191.22K |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 82.95M | -0.08% | 63,921 | 188.67M |
| 384 | UNCY | Unicycive Therapeutics, Inc. | 81.60M | 3.12% | 380,152 | - |
| 385 | DTIL | Precision BioSciences, Inc. | 81.40M | -4.66% | 60,481 | 698.00K |
| 386 | MGX | Metagenomi, Inc. | 81.07M | -2.70% | 541,817 | 33.77M |
| 387 | ATYR | aTyr Pharma, Inc. | 80.05M | 6.05% | 4,505,157 | 190.00K |
| 388 | HYFT | MindWalk Holdings Corp. | 79.85M | 1.76% | 314,241 | 18.21M |
| 389 | BYSI | BeyondSpring Inc. | 79.05M | 2.08% | 20,079 | 1.88M |
| 390 | FBIO | Fortress Biotech, Inc. | 77.66M | 3.57% | 186,630 | 59.30M |
| 391 | LITS | Lite Strategy, Inc. | 74.88M | 14.13% | 972,810 | - |
| 392 | PSTV | Plus Therapeutics, Inc. | 73.95M | 4.73% | 4,182,140 | 5.26M |
| 393 | ALXO | ALX Oncology Holdings Inc. | 73.90M | 16.95% | 758,147 | - |
| 394 | RPTX | Repare Therapeutics Inc. | 72.60M | - | 152,231 | 250.00K |
| 395 | NTRB | Nutriband Inc. | 72.46M | 9.04% | 20,004 | 2.58M |
| 396 | SPRB | Spruce Biosciences, Inc. | 71.56M | 6.46% | 78,847 | 1.30M |
| 397 | XBIT | XBiotech Inc. | 71.34M | -2.09% | 52,465 | - |
| 398 | CBUS | Cibus, Inc. | 71.05M | 4.38% | 165,559 | 4.85M |
| 399 | IMUX | Immunic, Inc. | 70.89M | 2.48% | 1,139,507 | - |
| 400 | GANX | Gain Therapeutics, Inc. | 70.46M | 3.16% | 854,942 | - |
| 401 | MNOV | MediciNova, Inc. | 69.65M | 1.43% | 178,199 | 134.60K |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 69.42M | 4.80% | 187,586 | - |
| 403 | STRO | Sutro Biopharma, Inc. | 69.20M | -13.36% | 1,272,469 | 105.65M |
| 404 | ABVC | ABVC BioPharma, Inc. | 68.59M | 2.46% | 48,621 | 797.92K |
| 405 | NSRX | Nasus Pharma Ltd. | 67.95M | -0.66% | 868 | - |
| 406 | ADAG | Adagene Inc. | 66.22M | -12.73% | 98,397 | 103.20K |
| 407 | COEP | Coeptis Therapeutics Holdings, Inc. | 66.09M | -1.72% | 55,740 | 263.56K |
| 408 | EQ | Equillium, Inc. | 65.45M | -13.04% | 381,985 | 16.55M |
| 409 | CRVO | CervoMed Inc. | 64.03M | -5.08% | 46,798 | 6.16M |
| 410 | ATHE | Alterity Therapeutics Limited | 63.39M | -1.14% | 11,201 | 3.57M |
| 411 | TCRX | TScan Therapeutics, Inc. | 61.86M | -6.03% | 727,497 | 6.96M |
| 412 | OSTX | OS Therapies Incorporated | 61.70M | 1.10% | 307,677 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 59.84M | -3.15% | 26,429 | - |
| 414 | IOBT | IO Biotech, Inc. | 59.40M | 6.96% | 1,687,285 | - |
| 415 | ACRV | Acrivon Therapeutics, Inc. | 59.14M | -6.00% | 1,016,426 | - |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 58.24M | -8.24% | 704,215 | - |
| 417 | IBO | Impact BioMedical Inc. | 57.59M | 3.13% | 59,685 | 25.00K |
| 418 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 57.52M | 0.82% | 4,597,749 | - |
| 419 | ANL | Adlai Nortye Ltd. | 57.20M | - | 15,718 | 1.94M |
| 420 | PYPD | PolyPid Ltd. | 57.14M | -3.95% | 53,329 | - |
| 421 | CVM | CEL-SCI Corporation | 56.27M | 6.02% | 90,815 | - |
| 422 | ICCC | ImmuCell Corporation | 55.18M | -3.33% | 7,994 | 28.27M |
| 423 | CUE | Cue Biopharma, Inc. | 53.88M | -2.05% | 226,296 | 8.29M |
| 424 | OTLK | Outlook Therapeutics, Inc. | 52.86M | 0.85% | 507,622 | 1.51M |
| 425 | HOWL | Werewolf Therapeutics, Inc. | 52.59M | -4.17% | 749,718 | 1.14M |
| 426 | SNTI | Senti Biosciences, Inc. | 51.01M | 7.73% | 66,070 | - |
| 427 | JSPR | Jasper Therapeutics, Inc. | 49.70M | -2.73% | 542,972 | - |
| 428 | JUNS | Jupiter Neurosciences, Inc. | 47.77M | -2.21% | 90,480 | - |
| 429 | CELU | Celularity Inc. | 47.51M | 5.33% | 64,175 | 44.59M |
| 430 | SKYE | Skye Bioscience, Inc. | 47.41M | 0.66% | 229,548 | - |
| 431 | ANVS | Annovis Bio, Inc. | 46.60M | 0.50% | 242,320 | - |
| 432 | IPSC | Century Therapeutics, Inc. | 46.20M | -0.96% | 1,160,919 | 114.13M |
| 433 | GRCE | Grace Therapeutics, Inc. | 45.37M | -1.64% | 51,145 | - |
| 434 | HYPD | Hyperion DeFi, Inc. | 44.82M | 13.58% | 441,653 | 44.44K |
| 435 | FGEN | FibroGen, Inc. | 44.60M | 0.27% | 22,692 | 7.35M |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 44.32M | -2.96% | 285,956 | - |
| 437 | KZR | Kezar Life Sciences, Inc. | 44.23M | -0.17% | 66,754 | - |
| 438 | GNTA | Genenta Science S.p.A. | 44.04M | 0.44% | 217,323 | - |
| 439 | BRNS | Barinthus Biotherapeutics plc | 43.69M | -10.08% | 116,960 | 14.97M |
| 440 | ALGS | Aligos Therapeutics, Inc. | 43.49M | -0.42% | 76,270 | 2.65M |
| 441 | INMB | INmune Bio, Inc. | 43.33M | - | 557,855 | 50.00K |
| 442 | PDSB | PDS Biotechnology Corporation | 42.82M | 2.49% | 1,007,828 | - |
| 443 | CALC | CalciMedica, Inc. | 42.48M | -0.65% | 15,079 | - |
| 444 | LVTX | LAVA Therapeutics N.V. | 42.35M | -0.62% | 54,576 | 4.99M |
| 445 | TPST | Tempest Therapeutics, Inc. | 42.27M | -0.21% | 31,957 | - |
| 446 | MRSN | Mersana Therapeutics, Inc. | 41.97M | 4.60% | 34,066 | 34.77M |
| 447 | XLO | Xilio Therapeutics, Inc. | 41.83M | -2.96% | 1,915,750 | 15.00M |
| 448 | RADX | Radiopharm Theranostics Limited | 41.42M | 10.28% | 5,727 | 8.20M |
| 449 | SER | Serina Therapeutics, Inc. | 41.20M | -5.10% | 47,044 | 130.00K |
| 450 | VERU | Veru Inc. | 41.09M | 1.59% | 137,287 | 16.89M |
| 451 | BCAB | BioAtla, Inc. | 40.32M | 7.23% | 785,316 | 11.00M |
| 452 | EVAX | Evaxion A/S | 40.30M | 1.92% | 315,069 | 7.65M |
| 453 | OKUR | OnKure Therapeutics, Inc. | 39.78M | -6.96% | 391,768 | - |
| 454 | ATNM | Actinium Pharmaceuticals, Inc. | 39.31M | -4.55% | 286,197 | 81.00K |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 37.70M | 2.03% | 265,585 | - |
| 456 | RNTX | Rein Therapeutics Inc. | 37.29M | 2.56% | 319,425 | - |
| 457 | MAIA | MAIA Biotechnology, Inc. | 36.95M | 1.82% | 260,082 | - |
| 458 | LTRN | Lantern Pharma Inc. | 36.93M | 1.79% | 93,447 | - |
| 459 | MURA | Mural Oncology plc | 36.21M | 0.24% | 107,010 | - |
| 460 | BTAI | BioXcel Therapeutics, Inc. | 35.95M | 2.81% | 793,326 | 868.00K |
| 461 | RNXT | RenovoRx, Inc. | 35.24M | -0.45% | 373,486 | 662.00K |
| 462 | GBIO | Generation Bio Co. | 34.42M | 1.79% | 41,770 | 15.27M |
| 463 | QNTM | Quantum BioPharma Ltd. | 33.91M | 3.73% | 40,763 | - |
| 464 | IGC | IGC Pharma, Inc. | 33.83M | -4.61% | 902,672 | 1.33M |
| 465 | DYAI | Dyadic International, Inc. | 33.82M | -4.62% | 241,232 | 4.14M |
| 466 | SABS | SAB Biotherapeutics, Inc. | 33.32M | 3.23% | 140,972 | 114.70K |
| 467 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 33.25M | 15.40% | 795,501 | 1.00M |
| 468 | KLTO | Klotho Neurosciences, Inc. | 32.92M | -3.17% | 901,314 | - |
| 469 | VRCA | Verrica Pharmaceuticals Inc. | 32.68M | -3.35% | 72,077 | 14.70M |
| 470 | NNVC | NanoViricides, Inc. | 32.07M | -3.16% | 300,127 | - |
| 471 | LIMN | Liminatus Pharma, Inc. | 31.53M | -8.98% | 397,596 | - |
| 472 | ANTX | AN2 Therapeutics, Inc. | 31.15M | 1.79% | 32,121 | - |
| 473 | APLM | Apollomics, Inc. | 30.43M | 6.46% | 27,300 | 198.00K |
| 474 | ITRM | Iterum Therapeutics plc | 29.07M | 3.79% | 754,815 | - |
| 475 | QTTB | Q32 Bio Inc. | 27.57M | -2.59% | 93,799 | - |
| 476 | BOLD | Boundless Bio, Inc. | 27.53M | -3.57% | 179,644 | - |
| 477 | PLUR | Pluri Inc. | 26.83M | 1.23% | 2,922 | 1.34M |
| 478 | IBIO | iBio, Inc. | 26.74M | -5.04% | 1,663,161 | 400.00K |
| 479 | RLYB | Rallybio Corporation | 26.13M | -2.11% | 313,800 | 674.00K |
| 480 | LPTX | Leap Therapeutics, Inc. | 25.96M | 12.27% | 1,927,001 | - |
| 481 | NERV | Minerva Neurosciences, Inc. | 25.95M | 1.92% | 124,109 | - |
| 482 | CLGN | CollPlant Biotechnologies Ltd. | 25.30M | -8.72% | 26,158 | 2.40M |
| 483 | NRXS | NeurAxis, Inc. | 25.08M | 0.40% | 86,065 | 3.22M |
| 484 | XCUR | Exicure, Inc. | 25.02M | -6.82% | 28,526 | 500.00K |
| 485 | CVKD | Cadrenal Therapeutics, Inc. | 24.86M | -0.45% | 13,222 | - |
| 486 | THAR | Tharimmune, Inc. | 24.73M | 0.96% | 6,199,550 | - |
| 487 | ENLV | Enlivex Therapeutics Ltd. | 24.29M | -0.99% | 88,963 | - |
| 488 | MBRX | Moleculin Biotech, Inc. | 24.20M | 7.12% | 1,971,413 | - |
| 489 | DARE | Daré Bioscience, Inc. | 24.12M | 1.10% | 152,083 | -17.70K |
| 490 | NXTC | NextCure, Inc. | 23.98M | -8.76% | 21,219 | - |
| 491 | NRSN | NeuroSense Therapeutics Ltd. | 23.29M | -9.71% | 302,584 | - |
| 492 | LEXX | Lexaria Bioscience Corp. | 23.13M | -3.70% | 166,862 | 615.92K |
| 493 | CTXR | Citius Pharmaceuticals, Inc. | 23.09M | 0.81% | 323,682 | - |
| 494 | AKTX | Akari Therapeutics, Plc | 22.82M | 3.72% | 122,897 | - |
| 495 | INTS | Intensity Therapeutics, Inc. | 22.33M | -6.22% | 5,745,286 | - |
| 496 | MTVA | MetaVia Inc. | 21.98M | 6.85% | 43,472,433 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 21.70M | -7.84% | 61,820 | 573.19K |
| 498 | LNAI | Lunai Bioworks Inc. | 21.63M | -8.52% | 1,972,078 | - |
| 499 | CASI | CASI Pharmaceuticals, Inc. | 21.38M | 3.76% | 33,412 | 31.56M |
| 500 | BCTX | BriaCell Therapeutics Corp. | 21.29M | 15.06% | 74,246 | - |
| 501 | CING | Cingulate Inc. | 20.91M | 1.36% | 55,510 | - |
| 502 | PMN | ProMIS Neurosciences, Inc. | 20.39M | -2.99% | 465,199 | - |
| 503 | PASG | Passage Bio, Inc. | 19.98M | -3.46% | 13,754 | - |
| 504 | CLSD | Clearside Biomedical, Inc. | 19.47M | -7.46% | 76,704 | 4.17M |
| 505 | LIXT | Lixte Biotechnology Holdings, Inc. | 19.39M | -0.93% | 50,970 | - |
| 506 | SYBX | Synlogic, Inc. | 18.60M | -3.05% | 10,393 | 8.00K |
| 507 | NCEL | NewcelX Ltd. | 18.28M | -3.37% | 41,707 | - |
| 508 | FBLG | FibroBiologics, Inc. | 18.13M | 5.13% | 1,100,619 | - |
| 509 | LSTA | Lisata Therapeutics, Inc. | 18.04M | -12.34% | 95,512 | 1.07M |
| 510 | PULM | Pulmatrix, Inc. | 17.71M | 1.51% | 6,047 | 3.00K |
| 511 | KAPA | Kairos Pharma, Ltd. | 17.69M | -2.00% | 108,810 | - |
| 512 | ICU | SeaStar Medical Holding Corporation | 16.71M | 6.31% | 650,034 | 766.00K |
| 513 | ALLR | Allarity Therapeutics, Inc. | 16.70M | 3.60% | 315,790 | - |
| 514 | CRIS | Curis, Inc. | 16.37M | -10.27% | 233,916 | 11.65M |
| 515 | HOTH | Hoth Therapeutics, Inc. | 16.31M | -3.91% | 295,546 | - |
| 516 | CANF | Can-Fite BioPharma Ltd. | 15.69M | -1.11% | 73,969 | 560.00K |
| 517 | LGVN | Longeveron Inc. | 15.52M | -4.29% | 335,846 | 1.44M |
| 518 | PCSA | Processa Pharmaceuticals, Inc. | 15.40M | -3.20% | 2,112,500 | - |
| 519 | GOVX | GeoVax Labs, Inc. | 15.26M | -1.34% | 528,661 | 6.14M |
| 520 | ATHA | Athira Pharma, Inc. | 15.18M | -3.99% | 43,504 | - |
| 521 | ABP | Abpro Holdings, Inc. | 14.99M | - | 67,389 | 183.00K |
| 522 | BLRX | BioLineRx Ltd. | 14.37M | -1.80% | 36,383 | 17.25M |
| 523 | COCP | Cocrystal Pharma, Inc. | 14.34M | 8.91% | 145,372 | - |
| 524 | TRAW | Traws Pharma, Inc. | 13.90M | -3.70% | 89,763 | 2.90M |
| 525 | BCDA | BioCardia, Inc. | 13.79M | 1.56% | 69,143 | 3.00K |
| 526 | LPCN | Lipocine Inc. | 13.76M | -3.79% | 20,527 | 4.32M |
| 527 | ERNA | Ernexa Therapeutics Inc. | 13.74M | 3.55% | 109,908 | 1,000.00 |
| 528 | CMMB | Chemomab Therapeutics Ltd. | 13.66M | 2.33% | 42,392 | - |
| 529 | PPCB | Propanc Biopharma, Inc. | 13.19M | -7.46% | 95,423 | - |
| 530 | OSRH | OSR Holdings, Inc. | 12.96M | -11.08% | 1,684,350 | 104.74K |
| 531 | IMRN | Immuron Limited | 12.21M | -1.20% | 125,633 | 4.78M |
| 532 | DWTX | Dogwood Therapeutics, Inc. | 12.06M | 1.15% | 19,857 | - |
| 533 | EDSA | Edesa Biotech, Inc. | 12.03M | 0.59% | 46,235 | - |
| 534 | ASBP | Aspire Biopharma Holdings, Inc. | 11.89M | -9.40% | 4,638,203 | - |
| 535 | BRTX | BioRestorative Therapies, Inc. | 11.86M | -4.29% | 21,520 | 605.20K |
| 536 | SNSE | Sensei Biotherapeutics, Inc. | 11.48M | -2.57% | 3,869 | - |
| 537 | SNGX | Soligenix, Inc. | 11.44M | 7.03% | 270,986 | 2.34K |
| 538 | APM | Aptorum Group Limited | 11.24M | 1.10% | 56,725 | - |
| 539 | MRKR | Marker Therapeutics, Inc. | 11.19M | -1.82% | 59,168 | 5.39M |
| 540 | BIVI | BioVie Inc. | 11.16M | -1.33% | 147,944 | - |
| 541 | ADXN | Addex Therapeutics Ltd | 10.90M | -2.97% | 5,258 | 210.35K |
| 542 | CLRB | Cellectar Biosciences, Inc. | 10.82M | -1.17% | 70,827 | - |
| 543 | PHGE | BiomX Inc. | 10.70M | 3.33% | 708,441 | - |
| 544 | AEON | AEON Biopharma, Inc. | 10.56M | -6.89% | 195,609 | - |
| 545 | EVGN | Evogene Ltd. | 10.40M | - | 30,197 | 9.44M |
| 546 | PLRZ | Polyrizon Ltd. | 10.28M | -5.24% | 269,443 | - |
| 547 | IMNN | Imunon, Inc. | 10.08M | 1.01% | 54,662 | - |
| 548 | XTLB | XTL Biopharmaceuticals Ltd. | 9.99M | - | 27,640 | 451.00K |
| 549 | NEUP | Neuphoria Therapeutics Inc. | 9.67M | -4.21% | 332,615 | 15.65M |
| 550 | ALZN | Alzamend Neuro, Inc. | 9.05M | -5.56% | 69,974 | - |
| 551 | VYNE | VYNE Therapeutics Inc. | 8.97M | -0.31% | 3,217,549 | 524.00K |
| 552 | PHIO | Phio Pharmaceuticals Corp. | 8.93M | 5.41% | 2,382,454 | - |
| 553 | MBIO | Mustang Bio, Inc. | 8.83M | -3.17% | 97,341 | - |
| 554 | BOLT | Bolt Biotherapeutics, Inc. | 8.73M | -4.81% | 44,032 | 4.17M |
| 555 | KZIA | Kazia Therapeutics Limited | 8.19M | -1.33% | 22,551 | 1.25M |
| 556 | KPRX | Kiora Pharmaceuticals, Inc. | 8.00M | 0.86% | 11,582 | 20.00K |
| 557 | RNAZ | TransCode Therapeutics, Inc. | 7.86M | 1.53% | 25,214 | - |
| 558 | CELZ | Creative Medical Technology Holdings, Inc. | 7.79M | 1.68% | 171,060 | 6.00K |
| 559 | LYRA | Lyra Therapeutics, Inc. | 7.58M | -5.92% | 39,101 | 770.00K |
| 560 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.56M | 5.13% | 44,342 | - |
| 561 | ACXP | Acurx Pharmaceuticals, Inc. | 7.22M | -5.40% | 57,771 | - |
| 562 | PPBT | Purple Biotech Ltd | 7.20M | 10.45% | 419,767 | - |
| 563 | APRE | Aprea Therapeutics, Inc. | 7.17M | 2.50% | 36,246 | 841.01K |
| 564 | MTNB | Matinas BioPharma Holdings, Inc. | 7.11M | 4.92% | 6,531 | - |
| 565 | ADIL | Adial Pharmaceuticals, Inc. | 7.11M | -0.43% | 249,711 | - |
| 566 | INAB | IN8bio, Inc. | 7.04M | -6.63% | 90,098 | - |
| 567 | NCNA | NuCana plc | 7.02M | 1.10% | 48,302 | - |
| 568 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.81M | 3.76% | 11,625 | 19.51K |
| 569 | GLMD | Galmed Pharmaceuticals Ltd. | 6.60M | -2.27% | 194,481 | - |
| 570 | JAGX | Jaguar Health, Inc. | 6.60M | 4.71% | 416,622 | 11.81M |
| 571 | GLTO | Galecto, Inc. | 6.56M | -14.95% | 41,168 | - |
| 572 | HCWB | HCW Biologics Inc. | 6.50M | -9.04% | 43,673 | 832.84K |
| 573 | TOVX | Theriva Biologics, Inc. | 6.49M | 1.43% | 1,539,795 | - |
| 574 | NBY | NovaBay Pharmaceuticals, Inc. | 6.37M | -0.93% | 164,883 | 7.86M |
| 575 | ENTO | Entero Therapeutics, Inc. | 6.19M | 12.72% | 143,267 | - |
| 576 | SILO | Silo Pharma, Inc. | 6.16M | -6.22% | 341,278 | 72.10K |
| 577 | ENSC | Ensysce Biosciences, Inc. | 6.11M | -0.48% | 52,019 | 7.41M |
| 578 | XBIO | Xenetic Biosciences, Inc. | 5.88M | -5.15% | 83,676 | 2.45M |
| 579 | PMCB | PharmaCyte Biotech, Inc. | 5.79M | -4.99% | 40,410 | - |
| 580 | CLDI | Calidi Biotherapeutics, Inc. | 5.76M | -13.86% | 1,289,169 | - |
| 581 | VIVS | VivoSim Labs, Inc. | 5.67M | -0.46% | 47,415 | 140.00K |
| 582 | TCRT | Alaunos Therapeutics, Inc. | 5.43M | - | 21,880 | 6.00K |
| 583 | GNPX | Genprex, Inc. | 5.25M | -10.23% | 230,577 | - |
| 584 | CYCN | Cyclerion Therapeutics, Inc. | 5.20M | -4.02% | 18,697 | 2.17M |
| 585 | KTTA | Pasithea Therapeutics Corp. | 5.14M | -4.52% | 110,697 | - |
| 586 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.05M | -5.38% | 42,359 | 984.49K |
| 587 | KALA | KALA BIO, Inc. | 5.01M | -2.66% | 175,204 | - |
| 588 | APVO | Aptevo Therapeutics Inc. | 4.83M | - | 1,213,785 | - |
| 589 | OGEN | Oragenics, Inc. | 4.61M | 0.21% | 68,001 | - |
| 590 | SPRC | SciSparc Ltd. | 4.46M | 3.00% | 53,375 | 1.31M |
| 591 | ONCO | Onconetix, Inc. | 4.25M | 2.62% | 13,559 | 1.33M |
| 592 | QLGN | Qualigen Therapeutics, Inc. | 4.24M | -2.72% | 235,659 | - |
| 593 | GRI | GRI Bio, Inc. | 4.23M | -4.55% | 100,113 | - |
| 594 | ARTL | Artelo Biosciences, Inc. | 4.17M | 17.84% | 89,070 | - |
| 595 | ELAB | PMGC Holdings Inc. | 4.04M | 0.18% | 45,970 | -605.53K |
| 596 | PTIX | Protagenic Therapeutics, Inc. | 3.94M | 0.49% | 44,011 | - |
| 597 | CNSP | CNS Pharmaceuticals, Inc. | 3.77M | -4.92% | 22,057 | - |
| 598 | CMND | Clearmind Medicine Inc. | 3.74M | -7.70% | 422,723 | - |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 3.35M | -0.38% | 21,554 | 104.90K |
| 600 | SCNI | Scinai Immunotherapeutics Ltd. | 3.25M | -3.77% | 39,490 | 1.15M |
| 601 | XRTX | XORTX Therapeutics Inc. | 3.21M | -4.01% | 62,425 | - |
| 602 | ENVB | Enveric Biosciences, Inc. | 3.17M | 1.16% | 44,428 | - |
| 603 | INDP | Indaptus Therapeutics, Inc. | 2.81M | -5.22% | 27,138 | - |
| 604 | MLEC | Moolec Science SA | 2.63M | 7.95% | 60,344 | 7.83M |
| 605 | GTBP | GT Biopharma, Inc. | 2.20M | 11.92% | 381,336 | - |
| 606 | VRAX | Virax Biolabs Group Limited | 2.09M | -3.86% | 188,706 | 6.33K |
| 607 | DRMA | Dermata Therapeutics, Inc. | 2.07M | 3.05% | 49,266 | - |
| 608 | REVB | Revelation Biosciences, Inc. | 1.67M | -2.91% | 70,011 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.57M | -2.79% | 73,465 | - |
| 610 | AZTR | Azitra, Inc. | 1.38M | -10.23% | 1,449,988 | 7.50K |
| 611 | PBM | Psyence Biomedical Ltd. | 1.35M | -8.08% | 114,201 | - |
| 612 | SLRX | Salarius Pharmaceuticals, Inc. | 1.24M | -13.48% | 273,537 | - |
| 613 | CDT | CDT Equity Inc. | 960.71K | 2.03% | 77,488 | - |
| 614 | ADTX | Aditxt, Inc. | 234.73K | - | 60,964 | 12.05K |